Evidence map›Paper›PMID 30065771›Full record

ArticleResearch in pharmaceutical sciences2018

The effect of

Zohreh Hosseinkhani, Mona Sadeghalvad, Fathemeh Norooznezhad, Reza Khodarahmi, Mohammad Fazilati, Azadeh Mahnam, Ali Fattahi, Kamran Mansouri

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Research in pharmaceutical sciences, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Association ofCase reports in medicine · 2023
    Article
  3. Article
  4. Genes · 2020
    Observational
  5. A Review of Danshen Combined with Clopidogrel in the Treatment of Coronary Heart Disease.Evidence-based complementary and alternative medicine : eCAM · 2019
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Zohreh HosseinkhaniMedical Biology Research Center, Kermanshah University of Medical Sciences, Kermanshah, I.R. Iran.
Mona SadeghalvadMedical Biology Research Center, Kermanshah University of Medical Sciences, Kermanshah, I.R. Iran.
Fathemeh NorooznezhadMedical Biology Research Center, Kermanshah University of Medical Sciences, Kermanshah, I.R. Iran.
Reza KhodarahmiMedical Biology Research Center, Kermanshah University of Medical Sciences, Kermanshah, I.R. Iran.
Mohammad FazilatiDepartment of Biochemistry, Payam-e Noor University of Isfahan, Isfahan, I.R. Iran.
Azadeh MahnamMedical Biology Research Center, Kermanshah University of Medical Sciences, Kermanshah, I.R. Iran.
Ali FattahiMedical Biology Research Center, Kermanshah University of Medical Sciences, Kermanshah, I.R. Iran.
Kamran MansouriMedical Biology Research Center, Kermanshah University of Medical Sciences, Kermanshah, I.R. Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Polymorphism in the genes encoding

Indexed as

Cytochrome P-450 CYP2C9International normalized ratioPolymorphismVitamin K1 epoxide reductaseWarfarin

Identifiers

PMID30065771
PMCPMC6040167

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.